Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the …

FE Lecouvet, DE Oprea-Lager, Y Liu, P Ost… - The Lancet …, 2018 - thelancet.com
Oligometastatic disease represents a clinical and anatomical manifestation between
localised and polymetastatic disease. In prostate cancer, as with other cancers, recognition …

Yield of bone scintigraphy for the detection of metastatic disease in treatment-naive prostate cancer: a systematic review and meta-analysis

CH Suh, AB Shinagare, AM Westenfield, NH Ramaiya… - Clinical Radiology, 2018 - Elsevier
Aim To evaluate the yield of staging bone scintigraphy in patients with treatment-naive
prostate cancer. Materials and methods A computerised search of the MEDLINE and …

[HTML][HTML] Diagnostic test accuracy study of 18F-sodium fluoride PET/CT, 99mTc-labelled diphosphonate SPECT/CT, and planar bone scintigraphy for diagnosis of bone …

RF Fonager, HD Zacho, NC Langkilde… - American journal of …, 2017 - ncbi.nlm.nih.gov
The aim of this study was to prospectively compare planar, bone scan (BS) versus
SPECT/CT and NaF PET/CT in detecting bone metastases in prostate cancer. Thirty-seven …

Is there still a role for computed tomography and bone scintigraphy in prostate cancer staging? An analysis from the EUREKA-1 database

D Gabriele, D Collura, M Oderda, I Stura, C Fiorito… - World journal of …, 2016 - Springer
Purpose According to the current guidelines, computed tomography (CT) and bone
scintigraphy (BS) are optional in intermediate-risk and recommended in high-risk prostate …

[PDF][PDF] Appropriate use criteria for bone scintigraphy in prostate and breast cancer: summary and excerpts

KJ Donohoe, EJ Cohen, F Giammarile, E Grady… - 2017 - Soc Nuclear Med
Nuclear medicine imaging studies are essential to the diagnosis and management of many
diseases, including neoplastic disease (1). Modern imaging studies allow noninvasive …

[HTML][HTML] Improved survival for patients with de novo metastatic prostate cancer in the last 20 years

KD Berg, FB Thomsen, MK Mikkelsen… - European Journal of …, 2017 - Elsevier
Introduction During recent years, several new life-prolonging therapeutic options have been
introduced for patients with metastatic prostate cancer (mPCa). The aim of the present study …

Diagnostic and prognostic significance of tartrate‐resistant acid phosphatase type 5b in newly diagnosed prostate cancer with bone metastasis: A real‐world multi …

G Yamamichi, T Kato, S Yumiba… - … Journal of Urology, 2023 - Wiley Online Library
Objectives Approximately, 90% of men with advanced prostate cancer will develop bone
metastasis. However, there have been few reports about noninvasive biomarker to detect …

Three-minute SPECT/CT is sufficient for the assessment of bone metastasis as add-on to planar bone scintigraphy: prospective head-to-head comparison to 11-min …

HD Zacho, JAB Manresa, R Aleksyniene, JA Ejlersen… - EJNMMI research, 2017 - Springer
Background The aim of this study is to assess whether ultra-fast acquisition SPECT/CT (UF-
SPECT/CT) can replace standard SPECT/CT (std-SPECT/CT) as “add-on” to whole-body …

The balance of patient involvement: Patients' and health professionals' perspectives on decision-making in the treatment of advanced prostate cancer

MM Løwe, PJS Osther, J Ammentorp… - Qualitative Health …, 2021 - journals.sagepub.com
Research has shown that involving patients in decisions on treatment may have positive
effects for patients. However, there are different understandings of what involving patients …

Staging 68 Ga-PSMA PET/CT in 963 consecutive patients with newly diagnosed prostate cancer: incidence and characterization of skeletal involvement

M Kesler, K Kerzhner, I Druckmann, J Kuten… - European Journal of …, 2022 - Springer
Purpose The aim of the study was to elaborate the incidence and type of skeletal
involvement in a large cohort of patients with newly diagnosed prostate cancer (PCa) …